Selectis Health (GBCS) Receivables (2013 - 2025)

Selectis Health (GBCS) has 12 years of Receivables data on file, last reported at $3.1 million in Q4 2025.

• Quarterly Receivables fell 6.29% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (down 6.29% YoY) and the FY2025 annual result came in at $3.1 million, down 6.29% from the prior year.
• Receivables eased to $3.1 million in Q4 2025 per GBCS's latest filing, from $3.2 million in the prior quarter.
• The five-year high for Receivables was $4.7 million in Q2 2022, with the low at $1.8 million in Q1 2024.
• Average Receivables over 5 years is $3.1 million, with a median of $3.1 million recorded in 2022.
• Year-over-year, Receivables surged 133.18% in 2021 and slumped 45.19% in 2023.
• Selectis Health's Receivables stood at $4.4 million in 2021, then dropped by 10.53% to $3.9 million in 2022, then slipped by 25.36% to $2.9 million in 2023, then rose by 14.32% to $3.3 million in 2024, then fell by 6.29% to $3.1 million in 2025.
• Business Quant data shows GBCS's Receivables at $3.1 million in Q4 2025, $3.2 million in Q3 2025, and $3.0 million in Q2 2025.